Market Overview

UPDATE: Jefferies & Company Upgrades Health Net to Hold, Raises PT

Related HNT
Earnings Scheduled For May 4, 2015
Biotech Bubble Valuations From Sam Islay
Why Health Net (HNT) Isn't Done Growing Earnings Yet - Tale of the Tape (Zacks)

In a report published Friday, Jefferies & Company upgraded its rating on Health Net (NYSE: HNT) to Hold, and raised its price target from $17.00 to $26.00.

Jefferies noted, “HNT's pricing agreement with California officials is a substantial risk mitigator. It narrows downside earnings risk, improves 2013 EPS, and addresses two key risks (SPDs; Duals) that were elements of our Underperform thesis. HNT is also making progress on a third concern, Commercial performance. We are upgrading to Hold and raising our PT to $26 on the improved outlook. This note analyzes scenarios for 2013 EPS that range to mid-$2.”

Health Net closed on Thursday at $25.35.

Latest Ratings for HNT

May 2015BarclaysMaintainsHold
Mar 2015BarclaysMaintainsUnderweight
Feb 2015BarclaysMaintainsUnderweight

View More Analyst Ratings for HNT
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Upgrades Analyst Ratings


Related Articles (HNT)

Around the Web, We're Loving...